Nearwater Capital Markets, Ltd
Position in RVMD — Revolution Medicines, Inc.
CIK 1915842
NEW YORK, NY
Position in RVMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$65,935,500
New position
Shares Held
678,000
first reported quarter
Ownership
0.319%
of shares outstanding
% of Portfolio
2.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Nearwater Capital Markets, Ltd holds $319,346,335 across 7 Biotechnology names. RVMD ranks #2 (20.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
2,150,400 | $113,369,088 | |
| 2 | RVMD |
Revolution Medicines, Inc.
This page
|
678,000 | $65,935,500 | |
| 3 | CELC |
Celcuity Inc.
|
473,100 | $53,999,634 | |
| 4 | INSM |
INSMED Inc
|
300,000 | $49,056,000 | |
| 5 | NKTR |
Nektar Therapeutics
|
261,500 | $18,814,925 | |
| 6 | ARQT |
Arcutis Biotherapeutics, Inc.
|
607,300 | $14,307,988 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,000 | $3,863,200 |
All Filings in RVMD
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $65,935,500 | 678,000 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||